Physician profile
Sneha Kumar
NPI 1811322001
$2,903.27
in general payments reported to CMS, 2019-2025
29 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,494 · 2020: $641 · 2021: $70.95 · 2022: $16.40 · 2023: $35.30 · 2024: $199 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $681.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $538.89 | 2019-2025 | Breztri |
| Glaxosmithkline, LLC. | $409.52 | 2019-2024 | Trelegy Ellipta |
| Pfizer INC. | $264.10 | 2019-2024 | |
| Lilly USA, LLC | $244.53 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.55 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $140.68 | 2019-2024 | Spravato |
| Novo Nordisk INC | $139.44 | 2019-2025 | Ozempic, Rybelsus |
| Abbott Laboratories | $92.71 | 2021-2024 | Freestyle Libre 3, Eterna, Freestyle Libre 2 |
| E.R. Squibb & Sons, L.L.C. | $84.16 | 2019-2025 | Cobenfy |
| Merck Sharp & Dohme LLC | $83.25 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.29 | 2019-2020 | |
| Amgen INC. | $79.96 | 2019-2024 | Krystexxa |
| Lundbeck LLC | $74.93 | 2025 | Rexulti |
| Abbvie INC. | $54.78 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $53.65 | 2019-2025 | Austedo Xr, Uzedy |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $52.69 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $52.64 | 2019 | |
| Globus Medical, INC. | $46.20 | 2025 | Senza, Omnia |
| Otsuka America Pharmaceutical, INC. | $34.65 | 2025 | Rexulti |
| Mylan Specialty L.P. | $34.13 | 2019 | |
| Neurocrine Biosciences, INC. | $29.33 | 2025 | |
| Inspire Medical Systems, INC. | $28.48 | 2025 | Inspire |
| Impulse Dynamics (USA) INC. | $24.41 | 2024 | Optimizer |
| Eisai INC. | $21.45 | 2025 | |
| Mannkind Corporation | $19.85 | 2025 | |
| Boston Scientific Corporation | $15.27 | 2025 | Wavewriter Alpha Prime 16 |
| Astellas Pharma US INC | $14.74 | 2019 | |
| Radius Health, INC. | $14.47 | 2020 | |
| Allergan, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sneha Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.